613 related articles for article (PubMed ID: 10984541)
1. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
Brines ML; Ghezzi P; Keenan S; Agnello D; de Lanerolle NC; Cerami C; Itri LM; Cerami A
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10526-31. PubMed ID: 10984541
[TBL] [Abstract][Full Text] [Related]
2. Effects of epoetin alfa on the central nervous system.
Cerami A; Brines ML; Ghezzi P; Cerami CJ
Semin Oncol; 2001 Apr; 28(2 Suppl 8):66-70. PubMed ID: 11395856
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective properties of epoetin alfa.
Cerami A; Brines M; Ghezzi P; Cerami C; Itri LM
Nephrol Dial Transplant; 2002; 17 Suppl 1():8-12. PubMed ID: 11812906
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.
Hellewell SC; Yan EB; Alwis DS; Bye N; Morganti-Kossmann MC
J Neuroinflammation; 2013 Dec; 10():156. PubMed ID: 24344874
[TBL] [Abstract][Full Text] [Related]
6. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin for neuroprotection: what is the evidence?
Eid T; Brines M
Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S109-15. PubMed ID: 12533271
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by erythropoietin administration after experimental traumatic brain injury.
Grasso G; Sfacteria A; Meli F; Fodale V; Buemi M; Iacopino DG
Brain Res; 2007 Nov; 1182():99-105. PubMed ID: 17935704
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
Juul S
Acta Paediatr Suppl; 2002; 91(438):36-42. PubMed ID: 12477263
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in neonatal brain protection: the past, the present and the future.
Kumral A; Tüzün F; Oner MG; Genç S; Duman N; Ozkan H
Brain Dev; 2011 Sep; 33(8):632-43. PubMed ID: 21109375
[TBL] [Abstract][Full Text] [Related]
12. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
Garcia-Rodriguez JC; Sosa-Teste I
ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects.
Girgenti MJ; Hunsberger J; Duman CH; Sathyanesan M; Terwilliger R; Newton SS
Biol Psychiatry; 2009 Aug; 66(3):267-74. PubMed ID: 19185286
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin for neonatal brain injury: opportunity and challenge.
Xiong T; Qu Y; Mu D; Ferriero D
Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
[TBL] [Abstract][Full Text] [Related]
15. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
[TBL] [Abstract][Full Text] [Related]
18. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
20. Role of erythropoietin in the brain.
Noguchi CT; Asavaritikrai P; Teng R; Jia Y
Crit Rev Oncol Hematol; 2007 Nov; 64(2):159-71. PubMed ID: 17482474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
